Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease. A Phase 3a, Indipendent, Multicentre, Two Parallel Arms, Randomized Controlled Trial

NCT03764605 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari as lead sponsor.

NCT NCT03764605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease. A Phase 3a, Indipendent, Multicentre, Two Parallel Arms, Randomized Controlled Trial
Lead sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase
Phase 3
Overall status
Unknown status
Start date
January 30, 2019
Completion date
January 30, 2022
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adpkd